22 min listen
Muthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Muthiah Vaduganathan, MD: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 RAs
FromDiabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
ratings:
Length:
26 minutes
Released:
Oct 8, 2020
Format:
Podcast episode
Description
In this episode of the Endocrine Outlook, listeners will hear a conversation with Muthiah Vaduganathan, MD, MPH, a cardiologist at Brigham and Women’s hospital. Vaduganathan was also the member of the writing committee for a recent AHA scientific statement regarding the cardionrenal protective benefits of SGLT2 inhibitors and GLP-1 receptor agonists.
Released:
Oct 8, 2020
Format:
Podcast episode
Titles in the series (94)
Diabetes Research & COVID-19 by Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives